DHA-paclitaxel

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDHA-paclitaxel
Drug Alias NamePaclitaxel-DHA conjugatePaclitaxel-docosahexaenoic acid conjugateTaxoprexin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsKidney NeoplasmsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsGermany +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmerican Regent Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheradexAmerican Regent Inc
Active IndicationsN/A
Inactive IndicationsKidney NeoplasmsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank